Netherlands · How much has Matisse Pharmaceuticals raised?
Matisse Pharmaceuticals has raised $16M across 1 round since 2026.
Netherlands · Series A startup
Who invested in Matisse Pharmaceuticals
Funding summaryUpdated 26 Oct 2026
$16Mraised across 1 round since 2026, from 1 source
- Latest round
- Series A, $16MSept 2026
- Investors
- 0
The rounds
- Sept 2026Series A$16M
No investor was named in the report.
Source recorded
Founders and team
From Matisse Pharmaceuticals's own website: 4 on the team.
- Marcel JacobsChief Executive Officer
- Gerry NicolaesChief Scientific Officer
- Kees GroenChief Development Officer
- Peter EkhartChief Operational Officer
Quick answers about Matisse Pharmaceuticals
When did Matisse Pharmaceuticals last raise?
Matisse Pharmaceuticals's most recent round was a Series A of $16M in Sept 2026.
What was Matisse Pharmaceuticals's biggest round?
Its most recent round, $16M in Sept 2026, is also its largest on record.
What stage is Matisse Pharmaceuticals at?
Matisse Pharmaceuticals's latest named round is a Series A, in Sept 2026.
Where is Matisse Pharmaceuticals based?
Matisse Pharmaceuticals is based in the Netherlands.
Companies like Matisse Pharmaceuticals
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.